ResearchMoz added Latest Research Report titled ” Infectious Disease Testing Market in the US 2015-2019 ” to it’s Large Report database.
About infectious disease testing
Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=517530
Manufacturers are developing diagnostic tests that can provide results in just a few minutes. For example, Alere developed Alere BinaxNOW Influenza A&B Card, which can detect influenza A & B in 15 minutes.
Technavio’s analysts forecast the infectious disease testing market in the US to grow at a CAGR of 5.81% over the period 2014-2019.
Covered in this report
The report covers the current scenario and the growth prospects of the infectious disease testing market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of equipment and consumables from molecular diagnostics, POCT diagnostic devices, and immunodiagnostics, which are used to detect infectious diseases:
The market is segmented based on technology:
Molecular diagnostic test
Read All In Vitro Diagnostics Market Research Reports @ http://www.researchmoz.us/in-vitro-diagnostics-market-reports-28.html
Table of Content
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
Key market highlights
PART 05: Market landscape
PART 06: Infectious disease landscape in the US
Reimbursement in US
Clinical laboratory improvement amendments (CLIA) waiver from US Food and Drug Administration
Five forces analysis
PART 07: Market segmentation by technology
Molecular diagnostic test
POCT for infectious diseases
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Albany NY, United States – 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://deep-research-report.blogspot.com/